Stroke Rehabilitation Market Size, Share & Industry Analysis By Product Type (Rehabilitation Equipment [Neurostimulation & Neuromodulation Systems, Cognitive, Speech & Upper-Limb & Hand Rehabilitation Systems] and Assistive Devices [Mobility & Orthotic Devices]), By Therapy Type (Physical Therapy, Occupational Therapy, Cognitive & Behavioral Therapy), By Stroke Type (Ischemic Stroke, Hemorrhagic Stroke, & Transient Ischemic Attack-related Rehabilitation), By Age Group (Adults & Pediatrics), By End User (Hospitals, Rehabilitation Centers, Homecare Settings), and Regional Forecast, 2026-2034

The global stroke rehabilitation market size was valued at USD 334.6 million in 2025 and is projected to grow from USD 364.6 million in 2026 to USD 755.9 million by 2034, exhibiting a CAGR of 9.5% during the forecast period.

Stroke rehabilitation is a customized therapy program that focuses on helping survivors relearn skills lost after a stroke. The growing prevalence of stroke, growing demand for stroke rehabilitation therapies, rising awareness of post-stroke recovery programs, and increasing investments in research are boosting the adoption of these devices in the market. The growing adoption of robotic rehabilitation, tele-rehabilitation, and personalized therapy solutions is further fueling demand for stroke rehabilitation devices.

• For instance, according to the 2024 data published by the Centers for Disease Control & Prevention (CDC), about 795,000 people experienced a stroke each year in the U.S.

The growing integration of digital rehabilitation, robotics, and personalized care solutions into these devices by major companies, including Bioventus and Ekso Bionics, is contributing to their global adoption.

Stroke Rehabilitation Market Trends

Growing Clinical Evidence Supporting Advanced Rehabilitation Technologies to Fuel Product Demand

Providers are increasingly shifting toward data-driven, technology-assisted, and home-enabled recovery models. Advanced rehabilitation devices, including upper-limb robotic therapy systems, robotic gait trainers, wearable motion sensors, virtual reality platforms, telerehabilitation platforms, and others, are enhancing patient engagement, therapy intensity, and progress monitoring. Stroke recovery often requires repetitive, task-based training, and device-based rehabilitation standardizes therapy delivery while reducing therapist workload.

Furthermore, increasing clinical evidence from research studies is strengthening technology adoption. Robotic technology and virtual reality are gaining widespread acceptance in stroke rehabilitation as they deliver intensive, repetitive, and engaging therapy, which is central for motor recovery.

• For instance, according to 2025 data published by The Cochrane Collaboration, a Cochrane review found that virtual reality (VR), when used in addition to standard therapy, can help stroke survivors regain arm movement. The findings suggest that VR could be a promising tool to boost rehabilitation efforts, particularly by increasing the amount of therapy patients receive.

Other Prominent Trends

• Increasing use of AI-based recovery monitoring tools
• Development of personalized rehabilitation programs

Market Dynamics

Market Drivers

Download Free sample to learn more about this report.

Increasing Prevalence of Chronic Conditions to Drive Market Growth

The increasing prevalence of chronic conditions, including stroke, is resulting in a rising number of patient admissions to healthcare settings. An aging population is also contributing to the rising adoption of stroke rehabilitation devices.

• For instance, according to 2023 data published by the Australian Institute of Health and Welfare, there were around 41,100 stroke events experienced in Australia.

This, along with the expansion of rehabilitation and recovery centers and rising healthcare expenditure, is augmenting the adoption of these devices in the market. Therefore, these factors, along with the growing emphasis of key companies on introducing R&D activities to launch novel devices, are anticipated to drive the adoption rate of these devices, further supporting the global stroke rehabilitation market growth.

Market Restraints

High Development and Implementation Costs to Hinder Market Growth

The high cost of advanced rehabilitation systems and therapy remains a major restraint on the global market. Stroke rehabilitation relies on advanced devices, including upper-limb robotic rehabilitation systems, robotic gait trainers, exoskeletons, virtual reality platforms, and others. These devices improve therapy intensity and patient engagement; however, their high upfront costs, software upgrade requirements, maintenance costs, staff training needs, and infrastructure requirements hamper adoption, especially among small hospitals and outpatient rehabilitation centers in low- and middle-income countries.

• For instance, according to the statistics published by GrabaRobot, exoskeleton robot prices range from USD 3,000 for passive industrial support suits to more than USD 150,000+ for powered medical rehabilitation systems.

Market Opportunities

Expansion of Healthcare Infrastructure in Developing Nations to Boost Industry Growth

Expansion of healthcare infrastructure in developing nations presents a major opportunity for the market. Increasing prevalence of stroke and limited access to structured rehabilitation services are driving the demand for expanded healthcare infrastructure in emerging economies. Government organizations and private healthcare providers are investing in rehabilitation departments, new hospitals, digital health platforms, outpatient therapy centers, community-based care, and home care services. These investments, along with growing healthcare expenditure, are improving access to healthcare facilities, thereby fueling the adoption of stroke rehabilitation devices, including neurostimulation devices, and other advanced rehabilitation technologies.

• According to 2025 statistics published by the International Trade Administration, healthcare expenditure was approximately USD 135.0 billion in Brazil.

Market Challenges

Limited Healthcare Access in Emerging Countries to Hamper Market Growth

The limited access to advanced healthcare infrastructure in many emerging nations remains a key challenge for the market. A shortage of specialists and limited rehabilitation capabilities restrict the adoption of advanced stroke rehabilitation devices in developing countries.

Furthermore, limited healthcare spending and inadequate reimbursement policies further limit the adoption of these technologies. Therefore, despite the growing prevalence of stroke, many patients in developing nations are unable to access advanced stroke rehabilitation therapies, thereby hindering the growth of the market.

• For instance, according to 2020 statistics published by the National Register of Health Establishments, the density of occupational therapists in Brazil was about 0.16 professionals per 10,000 inhabitants.

Other Prominent Challenges

• Long recovery timelines for severe stroke patients

SEGMENTATION ANALYSIS

By Product Type

Growing Burden of Stroke Boosted the Rehabilitation Equipment Segment Growth

Based on product type, the market is classified into rehabilitation equipment and assistive devices. Rehabilitation equipment is further divided into neurostimulation & neuromodulation systems, upper-limb & hand rehabilitation systems, and others. Assistive devices are further subdivided into mobility devices, orthotic devices, and others.

The rehabilitation equipment segment held the largest market share in 2025. The growth is owing to the increasing prevalence of stroke among patients, resulting in a growing number of stroke rehabilitation therapies globally. This, along with the rising focus of key companies on introducing innovative rehabilitation equipment, is further expected to contribute to the segment’s growth.

• For instance, according to the data published by the World Health Organization (WHO), around 93.8 million cases were registered globally in 2021.

To know how our report can help streamline your business, Speak to Analyst

The assistive devices segment is expected to grow at a CAGR of 9.2% over the forecast period.

By Therapy Type

Growing Number of Physical Therapists Led to the Dominance of the Physical Therapy Segment

Based on therapy type, the market is segmented into physical therapy, occupational therapy, cognitive & behavioral therapy, and others.

The physical therapy segment dominated the global market, holding a share of 45.9% in 2025. The segment’s growth is due to the increasing prevalence of stroke and the rising number of physical therapists, which are driving the adoption of physical therapy globally and supporting segmental growth.

• For instance, according to the 2026 statistics published by the Federation of State Boards of Physical Therapy (FSBPT), there were 322,992 unique physical therapists in the U.S.

The cognitive & behavioral therapy segment is set to grow at a CAGR of 10.4% during the forecast period.

By Stroke Type

Growing Prevalence of Ischemic Stroke Boosted the Segment Growth

Based on stroke type, the market is segmented into ischemic stroke, hemorrhagic stroke, and transient ischemic attack-related rehabilitation.

The ischemic stroke segment dominated the global market, holding a share of 74.0% in 2025. The segment’s growth is due to the increasing prevalence of ischemic stroke, resulting in a growing adoption of stroke rehabilitation devices globally.

• For instance, according to the 2024 statistics published by the Centers for Disease Control & Prevention (CDC), about 87% of all strokes were ischemic strokes in the U.S.

The hemorrhagic stroke segment is set to grow at a CAGR of 10.5% during the forecast period.

By Age Group

Increasing Prevalence of Stroke Among Adults Led to the Dominance of the Segment

Based on age group, the market is segmented into adults and pediatrics.

The adults segment dominated the global market in 2025. The growth is due to the increasing prevalence of stroke among adults, which is driving the adoption of stroke rehabilitation devices globally.

• For instance, according to the 2025 statistics published by the World Health Organization (WHO), about 1 in 4 adults is predicted to experience a stroke in their lifetime.

The pediatrics segment is set to exhibit a growth rate of 12.2% during the forecast period.

By End-user

Increasing Number of Hospitals Boosted the Segment Growth

Based on end user, the market is divided into hospitals, rehabilitation centers, homecare settings, and others.

The hospitals segment dominated the market in 2025. The growing prevalence of chronic conditions, rising adoption of stroke rehabilitation therapies in hospitals, and growing number of hospitals are some of the key factors contributing to the growth of the segment in the market. Furthermore, the segment is set to hold a 38.9% share in 2026.

• For instance, according to a 2022 survey published by Radar Healthcare, it was reported that there were about 8,300 hospitals in Japan.

The rehabilitation centers segment is projected to grow at a CAGR of 9.7% during the forecast period.

Stroke Rehabilitation Market Regional Outlook

Based on region, the market has been studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America

To get more information on the regional analysis of this market, Download Free sample

The North America market held the dominant share in 2024, valued at USD 129.8 million, and also maintained its leading share in 2025 with USD 140.5 million. The rising prevalence of stroke, developed healthcare infrastructure, rising healthcare expenditure, and technological advancements in stroke rehabilitation devices, improved gait rehabilitation therapies, and the rising number of stroke recovery clinics are some of the factors contributing to the growth of the region in the market.

• For instance, according to 2026 statistics published by the Centers for Medicare & Medicaid Services (CMS), healthcare spending is around USD 5.3 trillion in the U.S.

U.S. Stroke Rehabilitation Market

Based on North America’s strong contribution and the U.S. dominance within the region, the U.S. market is expected to reach around USD 134.0 million in 2026, accounting for roughly 36.8% of global sales.

Europe

Europe is projected to record a growth rate of 8.1% during the forecast period, which is the second-highest among all regions. The market is expected to reach a valuation of USD 86.6 million in 2026. Rising R&D activities by key companies to introduce novel devices are likely to support market growth.

U.K. Stroke Rehabilitation Market

The U.K. market is estimated to reach around USD 15.4 million in 2026, representing roughly 4.2% of global revenues.

Germany Stroke Rehabilitation Market

Germany’s market is projected to reach approximately USD 17.8 million in 2026, representing around 4.9% of global sales.

Asia Pacific

Asia Pacific is estimated to reach USD 93.3 million in 2026, securing the position of the third-largest region in the market. The region’s growth is driven by expanding healthcare systems and the growing adoption of cognitive rehabilitation therapy.

Japan Stroke Rehabilitation Market

The Japanese market is estimated to reach around USD 28.3 million in 2026, accounting for roughly 7.8% of global revenues. Japan has historically reported a relatively increasing prevalence of stroke, supporting a growing adoption of the product.

China Stroke Rehabilitation Market

China’s market is projected to be one of the largest worldwide, with 2026 revenues standing at around USD 22.6 million, representing roughly 6.2% of global sales.

India Stroke Rehabilitation Market

The Indian market in 2026 is estimated to reach around USD 14.7 million, accounting for roughly 4.0% of global revenues.

Latin America and Middle East & Africa  

The Latin America and Middle East & Africa regions are expected to witness moderate growth in this market during the forecast period. The Latin America market is set to reach a valuation of USD 18.3 million in 2026.  Growth is due to the growing number of neurological recovery programs and rising demand for post-acute stroke care in the region. The Middle East & Africa are also expected to grow, driven by healthcare investments and developed rehabilitation facilities across the region. In the Middle East & Africa, the GCC is set to reach USD 6.2 million in 2026.

South Africa Stroke Rehabilitation Market

The South Africa market is projected to reach around USD 2.6 million in 2026, representing roughly 0.7% of global revenues.

Competitive Landscape

Key Industry Players

Key Players are Focusing on Investing in R&D Activities to Reinforce their Market Presence 

Bioventus and Ekso Bionics are major companies in the market in 2025. A robust and diversified rehabilitation equipment portfolio, along with a significant emphasis on inorganic growth strategies globally, is one of the crucial factors supporting the dominance of these companies in the market. Furthermore, the growing focus of key companies on acquisitions and mergers is contributing to the global stroke rehabilitation market share.

• For instance, in March 2021, Bioventus Inc., a global company specializing in active healing innovations, acquired Bioness, Inc., a global leader in neuromodulation and rehabilitation medical devices, for USD 45.0 million in up-front consideration, with up to USD 65.0 million of contingent consideration tied to the achievement of certain key milestones. The acquisition strengthened Bioventus’s rehabilitation portfolio through its innovative peripheral nerve stimulation therapies and premium rehabilitation solutions.

Other key players, including Hocoma and others, are also growing their presence in the market, primarily through increased investment in R&D activities.

List of Key Stroke Rehabilitation Companies Profiled

• Hocoma (Switzerland)
• Motek Medical B.V. (Netherlands)
• Tyromotion GmbH (Austria)
• Ekso Bionics (U.S.)
• MicroTransponder Inc. (U.S.)
• Lifeward, Inc. (Israel)
• Reha Technology AG (Switzerland)
• Neofect (South Korea)
• B-Temia (Canada)
• Fesia Technology (Spain)

KEY INDUSTRY DEVELOPMENTS

• April 2026: CorTec GmbH received FDA Breakthrough Device Designation for its Brain Interchange System for stroke motor rehabilitation.
• September 2025: MedRhythms, Inc., a company in neurologic and physical rehabilitation, announced a strategic partnership with Edwards Health Care Services (EHCS), a provider of direct-to-home medical products.
• March 2025: MedRhythms, Inc., announced that MR-005, the company's neurorehabilitation system designed to support gait rehabilitation and motor function in adults with Parkinson's disease (PD), was classified as a Class II, Rx-only medical device by the U.S. Food and Drug Administration (FDA).
• January 2025: MedRhythms, Inc., announced that InTandem, the company's flagship rehabilitation system for chronic stroke gait impairment, received a final pricing determination from the Centers for Medicare and Medicaid Services (CMS).
• June 2019: ReWalk Robotics, Ltd., received FDA approval for the ReStore soft exo-suit system for sale to rehabilitation centers across the U.S.
• May 2019: ReWalk Robotics, Ltd., a manufacturer of robotic medical devices for individuals with lower limb disabilities, announced that the ReStore Exo-Suit for stroke rehabilitation received CE marking, clearing it for sale to rehabilitation clinics in the European Union.
• April 2019: Reha Technology AG launched the latest generation of its G-EOS robot-assisted gait trainer.

REPORT COVERAGE

The report provides a detailed global stroke rehabilitation market analysis and focuses on key aspects such as leading companies and market segmentation, including product type, therapy type, stroke type, age group, and end user. Besides this, the global report offers insights into the market trends and highlights key industry developments. In addition to the aforementioned factors, the report encompasses several factors that have contributed to the growth and advancement of the market in recent years.

Request for Customization   to gain extensive market insights.

Report Scope & Segmentation